All Stories

  1. Patterns of initial and first‐intensifying antidiabetic drug utilization among patients with type 2 diabetes mellitus in Scotland, 2010–2020: A retrospective population‐based cohort study

    Article • Diabetes Obesity and Metabolism, April 2024, Wiley

    Amanj Kurdi

  2. Caveats in reporting of national vaccine uptake

    Article • Journal of Global Health, February 2024, Edinburgh University Global Health Society

    Amanj Kurdi

  3. Analysis of the use of antibiotics by AWaRe categories during the COVID-19 pandemic in hospitals across Scotland: a national population-based study

    Article • European Journal of Hospital Pharmacy, February 2024, BMJ

    Amanj Kurdi

  4. Antimicrobial stewardship capacity and antibiotic utilisation practices in the Cape Coast Teaching Hospital, Ghana: A point prevalence survey study

    Article • PLoS ONE, January 2024, PLOS

    Amanj Kurdi

  5. Involving Patients and Clinicians in the Design of Wireframes for Cancer Medicines Electronic Patient Reported Outcome Measures in Clinical Care: Mixed Methods Study

    Article • JMIR Formative Research, December 2023, JMIR Publications Inc.

    Amanj Kurdi

  6. The Disruptive Impact of COVID-19 on the Utilization of Cancer Chemotherapy-Related Healthcare Assistance at the Principal Nationwide Referral Hospital in Kenya

    Article • Cureus, December 2023, Springer Science + Business Media

    Amanj Kurdi

  7. Selling antibiotics without prescriptions among community pharmacies and drug outlets: a simulated client study from Ghana

    Article • Expert Review of Anti-infective Therapy, November 2023, Taylor & Francis

    Amanj Kurdi

  8. Estimated indirect costs of haemodialysis versus peritoneal dialysis from a patients’ perspective at an Academic Hospital in Pretoria, South Africa

    Article • BMC Health Services Research, October 2023, Springer Science + Business Media

    Amanj Kurdi

  9. Quality of ethnicity data within Scottish health records and implications of misclassification for ethnic inequalities in severe COVID-19: a national linked data study

    Article • Journal of Public Health, October 2023, Oxford University Press (OUP)

    Amanj Kurdi, Holly Tibble

  10. Data Resource Profile: The Hospital Electronic Prescribing and Medicines Administration (HEPMA) National Data Collection in Scotland

    Article • International Journal for Population Data Science, October 2023, Swansea University

    Amanj Kurdi

  11. Current rates of purchasing of antibiotics without a prescription across sub-saharan Africa; rationale and potential programmes to reduce inappropriate dispensing and resistance

    Article • Expert Review of Anti-infective Therapy, September 2023, Taylor & Francis

    Amanj Kurdi

  12. Understanding and reporting odds ratios as rate-ratio estimates in case-control studies

    Article • Journal of Global Health, September 2023, Edinburgh University Global Health Society

    Amanj Kurdi

  13. Ethnic inequalities in positive SARS-CoV-2 tests, infection prognosis, COVID-19 hospitalisations and deaths: analysis of 2 years of a record linked national cohort study in Scotland

    Article • Journal of Epidemiology & Community Health, July 2023, BMJ

    Amanj Kurdi, Holly Tibble

  14. Assessment of the quality of antimicrobial prescribing among hospitalized patients in a teaching hospital in Ghana: findings and implications

    Article • Hospital Practice, July 2023, Taylor & Francis

    Amanj Kurdi

  15. Trends in the Cost of Medicines, Consultation Fees and Clinic Visits in Malaysia’s Private Primary Healthcare System: Employer Health Insurance Coverage

    Article • Journal of Multidisciplinary Healthcare, June 2023, Taylor & Francis

    Amanj Kurdi

  16. Airport based pharmacies; products, services and challenges essential for patients in a global travel landscape

    Article • Journal of the American Pharmacists Association, June 2023, Elsevier

    Amanj Kurdi

  17. Involving Patients and Clinicians in the Design of Wireframes for Cancer Medicines Electronic Patient Reported Outcome Measures in Clinical Care: Mixed Methods Study (Preprint)

    Article • April 2023, JMIR Publications Inc.

    Amanj Kurdi

  18. Corrigendum to “Utilisation Trend of Long-Acting Insulin Analogues including Biosimilars across Europe: Findings and Implications”

    Article • BioMed Research International, April 2023, Hindawi Publishing Corporation

    Amanj Kurdi, Professor Mihajlo (Michael) Jakovljevic MD, PhD, MAE

  19. Meta‐analysis of Factors Associated with Antidiabetic Drug Prescribing for Type 2 Diabetes Mellitus

    Article • European Journal of Clinical Investigation, April 2023, Wiley

    Amanj Kurdi

  20. Perceptions of and Preparedness for the Application of Pharmacoeconomics in Practice, among Final Year Bachelor of Pharmacy Students in South Africa: A National Cross-Sectional Study

    Article • Pharmacy, March 2023, MDPI AG

    Amanj Kurdi

  21. Risk Awareness and Demographic Characteristics Associated With the Use of Sexual Enhancement Supplements Among University Staff: A Cross-Sectional Study in the United Arab Emirates

    Article • American Journal of Men s Health, March 2023, SAGE Publications

    Amanj Kurdi

  22. Evaluation of duration of antibiotic therapy across hospitals in Scotland including the impact of COVID-19 pandemic: a segmented interrupted time series analysis

    Article • Expert Review of Anti-infective Therapy, February 2023, Taylor & Francis

    Amanj Kurdi

  23. The impact of the COVID-19 pandemic on cardiovascular disease prevention and management

    Article • Nature Reports Stem Cells, January 2023, Springer Science + Business Media

    Amanj Kurdi

  24. Shedding light on community pharmacist–directed point-of-care screening and education for patients with kidney stones: Implications and future research

    Article • Research in Social and Administrative Pharmacy, January 2023, Elsevier

    Amanj Kurdi

  25. Ongoing Efforts to Improve Antimicrobial Utilization in Hospitals among African Countries and Implications for the Future

    Article • Antibiotics, December 2022, MDPI AG

    Amanj Kurdi

  26. Assessing medication use patterns in patients hospitalised with COVID-19: a retrospective study

    Article • BMJ Open, December 2022, BMJ

    Amanj Kurdi, Holly Tibble

  27. Uptake of COVID-19 treatments in Scotland

    Article • The Lancet, December 2022, Elsevier

    Holly Tibble, Amanj Kurdi

  28. Effects of the COVID-19 pandemic on secondary care for cardiovascular disease in the UK: an electronic health record analysis across three countries

    Article • European Heart Journal - Quality of Care and Clinical Outcomes, November 2022, Oxford University Press (OUP)

    Amanj Kurdi

  29. Access to non-prescription medicines via vending machines: key considerations to help transfer the self-care concept to the next generation while managing safety risks

    Article • Journal of Pharmaceutical Health Services Research, November 2022, Oxford University Press (OUP)

    Amanj Kurdi

  30. An umbrella review and meta‐analysis of renin‐angiotensin system drugs use and COVID ‐19 outcomes

    Article • European Journal of Clinical Investigation, October 2022, Wiley

    Amanj Kurdi

  31. Appropriateness of surgical antimicrobial prophylaxis in a teaching hospital in Ghana: findings and implications

    Article • JAC-Antimicrobial Resistance, September 2022, Oxford University Press (OUP)

    Amanj Kurdi

  32. Tackling antimicrobial resistance across sub-Saharan Africa: current challenges and implications for the future

    Article • Expert Opinion on Drug Safety, August 2022, Taylor & Francis

    Amanj Kurdi

  33. A national, multicentre web-based point prevalence survey of antimicrobial use in community healthcare centres across South Africa and the implications

    Article • Hospital Practice, August 2022, Taylor & Francis

    Amanj Kurdi

  34. Prevalence of bacterial coinfection and patterns of antibiotics prescribing in patients with COVID-19: A systematic review and meta-analysis

    Article • PLoS ONE, August 2022, PLOS

    Amanj Kurdi

  35. Acceptability and Willingness of UAE Residents to Use OTC Vending Machines to Deliver Self-Testing Kits for COVID-19 and the Implications

    Article • Journal of Multidisciplinary Healthcare, August 2022, Taylor & Francis

    Amanj Kurdi

  36. Impact of Parental Knowledge and Beliefs on HPV Vaccine Hesitancy in Kenya—Findings and Implications

    Article • Vaccines, July 2022, MDPI AG

    Amanj Kurdi

  37. Characteristics and Management of Children With Suspected COVID-19 Admitted to Hospitals in India: Implications for Future Care

    Article • Cureus, July 2022, Cureus, Inc.

    Amanj Kurdi

  38. Regional variation in longitudinal trajectories of primary care opioids prescribing across Health Boards in Scotland: a population-based study

    Article • Expert Review of Clinical Pharmacology, July 2022, Taylor & Francis

    Amanj Kurdi

  39. Assessing knowledge, attitude and practice of community pharmacists on the pain management and implications in UAE children

    Article • Pharmacy Practice, July 2022, JCFCorp SG PTE LTD

    Amanj Kurdi

  40. Development and Validation of a Tool to Improve Community Pharmacists’ Surveillance Role in the Safe Dispensing of Herbal Supplements

    Article • Frontiers in Pharmacology, July 2022, Frontiers

    Amanj Kurdi

  41. Evaluation of antibiotic prescribing for ambulatory patients seeking primary dental care services in a public hospital in Ghana: a clinical audit study

    Article • JAC-Antimicrobial Resistance, July 2022, Oxford University Press (OUP)

    Amanj Kurdi

  42. What patient assessment skills do pharmacist independent prescribers require to prescribe immunomodulators in myeloma?

    Article • Journal of Oncology Pharmacy Practice, June 2022, SAGE Publications

    Amanj Kurdi

  43. The impact of the COVID-19 pandemic lockdown measures on the prescribing trends and utilization of opioids in the English primary care setting: segmented-liner regression analysis

    Article • Expert Review of Clinical Pharmacology, June 2022, Taylor & Francis

    Amanj Kurdi

  44. Challenges and Opportunities With Routinely Collected Data on the Utilization of Cancer Medicines. Perspectives From Health Authority Personnel Across 18 European Countries

    Article • Frontiers in Pharmacology, June 2022, Frontiers

    Amanj Kurdi, Guenka Petrova

  45. An umbrella review and meta-analysis of the use of renin-angiotensin system drugs and COVID-19 outcomes: what do we know so far?

    Article • May 2022, Authorea, Inc.

    Amanj Kurdi

  46. Assessing the management of patients with type 2 diabetes in Bangladesh during pre- and post-COVID-19 era and the implications: A pilot study

    Article • Journal of Applied Pharmaceutical Science, May 2022, Journal of Applied Pharmaceutical Science

    Amanj Kurdi

  47. Top unresolved ethical challenges and dilemmas faced by community pharmacists in providing pharmaceutical care: Drawing the line between ethical challenges and the quality of the pharmaceutical care

    Article • Research in Social and Administrative Pharmacy, May 2022, Elsevier

    Amanj Kurdi

  48. An umbrella review and meta-analysis of the use of renin-angiotensin system drugs and COVID-19 outcomes: what do we know so far?

    Article • International Journal of Pharmacy Practice, April 2022, Oxford University Press (OUP)

    Amanj Kurdi

  49. Obesity association with antidiabetic drugs’ prescription among patients with type 2 diabetes mellitus: a systematic review and meta-analysis

    Article • International Journal of Pharmacy Practice, April 2022, Oxford University Press (OUP)

    Amanj Kurdi

  50. The impact of the COVID-19 pandemic lockdown measures on the prescribing trends and utilisation of opioids in the English primary care setting: a segmented-linear regression analysis

    Article • International Journal of Pharmacy Practice, April 2022, Oxford University Press (OUP)

    Amanj Kurdi

  51. Prevalence of bacterial coinfection and patterns of antibiotics prescribing in patients with COVID-19: a systematic review and meta-analysis

    Article • International Journal of Pharmacy Practice, April 2022, Oxford University Press (OUP)

    Amanj Kurdi

  52. An umbrella review and meta-analysis of the use of renin-angiotensin system drugs and COVID-19 outcomes: what do we know so far?

    Article • March 2022, Cold Spring Harbor Laboratory Press

    Amanj Kurdi

  53. Biosimilars are essential for sustainable healthcare systems; however, key challenges remain as seen with long-acting insulin analogues

    Article • Journal of Applied Pharmaceutical Science, March 2022, Journal of Applied Pharmaceutical Science

    Amanj Kurdi

  54. Barriers and facilitators of adherence to antiretroviral treatment at a public health facility in Ghana: a mixed method study

    Article • Hospital Practice, February 2022, Taylor & Francis

    Amanj Kurdi

  55. Management of Children Admitted to Hospitals across Bangladesh with Suspected or Confirmed COVID-19 and the Implications for the Future: A Nationwide Cross-Sectional Study

    Article • Antibiotics, January 2022, MDPI AG

    Amanj Kurdi, Professor Dr Mainul Haque

  56. Access to community pharmacy services for people with disabilities: Barriers, challenges, and opportunities

    Article • Research in Social and Administrative Pharmacy, January 2022, Elsevier

    Amanj Kurdi

  57. Opportunities and challenges when using record linkage of routinely collected electronic health care data to evaluate outcomes of systemic anti-cancer treatment in clinical practice

    Article • Health Informatics Journal, January 2022, SAGE Publications

    Amanj Kurdi

  58. Patients' knowledge and practice on disposal of medicines kept in households in South Africa: Findings and implications

    Article • Journal of Research in Pharmacy Practice, January 2022, Medknow

    Amanj Kurdi

  59. Using Administrative Data from Public Health and Drug Programs

    Article • January 2022, Springer Science + Business Media

    Amanj Kurdi

  60. Challenges and Innovations Brought about by the COVID-19 Pandemic Regarding Medical and Pharmacy Education Especially in Africa and Implications for the Future

    Article • Healthcare, December 2021, MDPI AG

    Amanj Kurdi, Professor Dr Mainul Haque

  61. What matters to patients and clinicians when discussing the impact of cancer medicines on health-related quality of life? Consensus-based mixed methods approach in prostate cancer

    Article • Supportive Care in Cancer, December 2021, Springer Science + Business Media

    Amanj Kurdi

  62. Key issues surrounding the management of non-communicable diseases including the management of diabetes post COVID-19 among developing countries with a specific focus on Bangladesh

    Article • Journal of Applied Pharmaceutical Science, December 2021, Journal of Applied Pharmaceutical Science

    Amanj Kurdi

  63. A national, multicentre web-based point prevalence survey of antimicrobial use and quality indices among hospitalised paediatric patients across South Africa

    Article • Journal of Global Antimicrobial Resistance, December 2021, Elsevier

    Amanj Kurdi

  64. Retrospective cohort study to evaluate medication use in patients hospitalised with COVID-19 in Scotland: protocol for a national observational study

    Article • BMJ Open, November 2021, BMJ

    Amanj Kurdi

  65. Use of Sedative‐Hypnotic Medications and Risk of Dementia: A Systematic Review and Meta‐Analysis

    Article • British Journal of Clinical Pharmacology, October 2021, Wiley

    Amanj Kurdi

  66. Utilisation Trend of Long-Acting Insulin Analogues including Biosimilars across Europe: Findings and Implications

    Article • BioMed Research International, October 2021, Hindawi Publishing Corporation

    Amanj Kurdi, Professor Mihajlo (Michael) Jakovljevic MD, PhD, MAE, Guenka Petrova

  67. Frequency and determinants of domestic violence against Iranian women during the COVID-19 pandemic: a national cross-sectional survey

    Article • BMC Public Health, September 2021, Springer Science + Business Media

    Amanj Kurdi

  68. Opioids and Gabapentinoids Utilisation and Their Related-Mortality Trends in the United Kingdom Primary Care Setting, 2010–2019: A Cross-National, Population-Based Comparison Study

    Article • Frontiers in Pharmacology, September 2021, Frontiers

    Amanj Kurdi

  69. Pilot Study on the Current Management of Children with COVID-19 In Hospitals in Bangladesh; Findings and Implications

    Article • Bangladesh Journal of Medical Science, September 2021, Bangladesh Journals Online (BanglaJOL)

    Amanj Kurdi

  70. Validity of Pneumonia Severity Assessment Scores in Africa and South Asia: A Systematic Review and Meta-Analysis

    Article • Healthcare, September 2021, MDPI AG

    Amanj Kurdi

  71. Antimicrobial Stewardship Activities in Public Healthcare Facilities in South Africa: A Baseline for Future Direction

    Article • Antibiotics, August 2021, MDPI AG

    Amanj Kurdi

  72. Health systems, population and patient challenges for achieving universal health coverage for hypertension in Ghana

    Article • Health Policy and Planning, July 2021, Oxford University Press (OUP)

    Amanj Kurdi

  73. Evidence-based public policy making for medicines across countries: findings and implications for the future

    Article • Journal of Comparative Effectiveness Research, July 2021, Future Medicine

    Amanj Kurdi

  74. Polypharmacy definition and prevalence in heart failure: a systematic review

    Article • Heart Failure Reviews, July 2021, Springer Science + Business Media

    Amanj Kurdi

  75. Current utilisation patterns for long-acting insulin analogues including biosimilars among selected Asian countries and the implications for the future

    Article • Current Medical Research and Opinion, June 2021, Taylor & Francis

    Amanj Kurdi, Professor Mihajlo (Michael) Jakovljevic MD, PhD, MAE, Professor Dr Mainul Haque

  76. The Current Situation Regarding Long-Acting Insulin Analogues Including Biosimilars Among African, Asian, European, and South American Countries; Findings and Implications for the Future

    Article • Frontiers in Public Health, June 2021, Frontiers

    Amanj Kurdi, Professor Mihajlo (Michael) Jakovljevic MD, PhD, MAE, Guenka Petrova

  77. A multicentre point prevalence study of antibiotics utilization in hospitalized patients in an urban secondary and a tertiary healthcare facilities in Nigeria: findings and implications

    Article • Expert Review of Anti-infective Therapy, June 2021, Taylor & Francis

    Amanj Kurdi

  78. Strategies to Improve Antimicrobial Utilization with a Special Focus on Developing Countries

    Article • Life, June 2021, MDPI AG

    Amanj Kurdi, Professor Dr Mainul Haque

  79. Activities in Namibia to Limit the Prevalence and Mortality from COVID-19 Including Community Pharmacy Activities and the Implications

    Article • Scholars Academic Journal of Pharmacy, May 2021, SASPR Edu International Pvt. Ltd

    Amanj Kurdi

  80. Assessment of adherence to pneumonia guidelines and its determinants in an ambulatory care clinic in Ghana: findings and implications for the future

    Article • JAC-Antimicrobial Resistance, April 2021, Oxford University Press (OUP)

    Amanj Kurdi

  81. Influence of pharmaceutical services organization on the availability of essential medicines in a public health system

    Article • Journal of Comparative Effectiveness Research, March 2021, Future Medicine

    Amanj Kurdi

  82. A point prevalence survey of antimicrobial utilisation patterns and quality indices amongst hospitals in South Africa; findings and implications

    Article • Expert Review of Anti-infective Therapy, March 2021, Taylor & Francis

    Amanj Kurdi

  83. Development of a web-based application to improve data collection of antimicrobial utilization in the public health care system in South Africa

    Article • Hospital Practice, March 2021, Taylor & Francis

    Amanj Kurdi

  84. Potential approaches for the pricing of cancer medicines across Europe to enhance the sustainability of healthcare systems and the implications

    Article • Expert Review of Pharmacoeconomics & Outcomes Research, February 2021, Taylor & Francis

    Amanj Kurdi, Guenka Petrova

  85. Key Issues Surrounding Appropriate Antibiotic Use for Prevention of Surgical Site Infections in Low- and Middle-Income Countries: A Narrative Review and the Implications

    Article • International Journal of General Medicine, February 2021, Taylor & Francis

    Amanj Kurdi

  86. Utilisation, Availability and Price Changes of Medicines and Protection Equipment for COVID-19 Among Selected Regions in India: Findings and Implications

    Article • Frontiers in Pharmacology, January 2021, Frontiers

    Amanj Kurdi

  87. Rapid Assessment of the Potential Paucity and Price Increases for Suggested Medicines and Protection Equipment for COVID-19 Across Developing Countries With a Particular Focus on Africa and the Implications

    Article • Frontiers in Pharmacology, January 2021, Frontiers

    Amanj Kurdi

  88. Changes in availability, utilization, and prices of medicines and protection equipment for COVID-19 in an Urban population of Northern Nigeria

    Article • Journal of Research in Pharmacy Practice, January 2021, Medknow

    Amanj Kurdi

  89. Prevalence rate of spontaneously reported adverse events and determinants of serious adverse events amongst three outpatient care settings in ghana: findings and implications

    Article • Advances in Human Biology, January 2021, Medknow

    Amanj Kurdi

  90. COVID-19, health care and self-medication issues in resource-limited settings: Findings and implications based on experiences in Ghana

    Article • Advances in Human Biology, January 2021, Medknow

    Amanj Kurdi

  91. Health-Care professionals' knowledge and practice regarding disposal of medicines in primary health-care facilities in South Africa: Impact and implications

    Article • Journal of Research in Pharmacy Practice, January 2021, Medknow

    Amanj Kurdi

  92. Rapid Assessment of Price Instability and Paucity of Medicines and Protection for COVID-19 Across Asia: Findings and Public Health Implications for the Future

    Article • Frontiers in Public Health, December 2020, Frontiers

    Amanj Kurdi

  93. A systematic review and meta‐analysis of the use of renin‐angiotensin system drugs and COVID‐19 clinical outcomes: What is the evidence so far?

    Article • Pharmacology Research & Perspectives, October 2020, Wiley

    Amanj Kurdi

  94. Supporting antimicrobial stewardship in Ghana: evaluation of the impact of training on knowledge and attitudes of healthcare professionals in two hospitals

    Article • JAC-Antimicrobial Resistance, October 2020, Oxford University Press (OUP)

    Amanj Kurdi

  95. A multicentre point prevalence survey of hospital antibiotic prescribing and quality indices in the Kurdistan Regional Government of Northern Iraq: The need for urgent action

    Article • Expert Review of Anti-infective Therapy, October 2020, Taylor & Francis

    Amanj Kurdi

  96. Response to the Novel Corona Virus (COVID-19) Pandemic Across Africa: Successes, Challenges, and Implications for the Future

    Article • Frontiers in Pharmacology, September 2020, Frontiers

    Amanj Kurdi, Dr Wafaa M. Rashed

  97. Supporting global antimicrobial stewardship: antibiotic prophylaxis for the prevention of surgical site infection in low- and middle-income countries (LMICs): a scoping review and meta-analysis

    Article • JAC-Antimicrobial Resistance, September 2020, Oxford University Press (OUP)

    Amanj Kurdi

  98. A systematic review and meta-analysis of the use of renin-angiotensin system drugs and COVID-19 clinical outcomes: What is the evidence so far?

    Article • August 2020, Authorea, Inc.

    Amanj Kurdi

  99. Compliance with South Africa’s Antimicrobial Resistance National Strategy Framework: are we there yet?

    Article • Journal of Chemotherapy, July 2020, Taylor & Francis

    Amanj Kurdi

  100. Availability and price changes of potential medicines and equipment for the prevention and treatment of COVID-19 among pharmacy and drug stores in Bangladesh; findings and implications

    Article • Bangladesh Journal of Medical Science, July 2020, Bangladesh Journals Online (BanglaJOL)

    Amanj Kurdi

  101. Lessons from the failure of implementing the ‘Better Care Better Value’ prescribing indicator for renin–angiotensin system drugs in England: a qualitative study of general practitioners’ perceptions using behavioural change framework

    Article • BMJ Open, June 2020, BMJ

    Amanj Kurdi

  102. Ongoing and planned activities to improve the management of patients with Type 1 diabetes across Africa; implications for the future

    Article • Hospital Practice, May 2020, Taylor & Francis

    Amanj Kurdi

  103. Evaluation of the prescribing decision support system Synonyms in a primary care setting: a mixed‐method study

    Article • International Journal of Pharmacy Practice, May 2020, Wiley

    Amanj Kurdi

  104. Real‐world evaluation of the impact of statin intensity on adherence and persistence to therapy: A Scottish population‐based study

    Article • British Journal of Clinical Pharmacology, April 2020, Wiley

    Amanj Kurdi

  105. Use of record linkage to evaluate treatment outcomes and trial eligibility in a real‐world metastatic prostate cancer population in Scotland

    Article • Pharmacoepidemiology and Drug Safety, April 2020, Wiley

    Amanj Kurdi

  106. Translation and Validation of the Farsi Version of the Pain Management Self-Efficacy Questionnaire

    Article • Journal of Pain Research, April 2020, Taylor & Francis

    Amanj Kurdi

  107. Review of Ongoing Activities and Challenges to Improve the Care of Patients With Type 2 Diabetes Across Africa and the Implications for the Future

    Article • Frontiers in Pharmacology, March 2020, Frontiers

    Amanj Kurdi

  108. Antimicrobial point prevalence surveys in two Ghanaian hospitals: opportunities for antimicrobial stewardship

    Article • JAC-Antimicrobial Resistance, February 2020, Oxford University Press (OUP)

    Amanj Kurdi

  109. Evaluation of the clinical practice of aminoglycoside use in paediatric patients in Kenya: findings and implications for lower-middle income countries

    Article • JAC-Antimicrobial Resistance, January 2020, Oxford University Press (OUP)

    Amanj Kurdi

  110. Fixed dose drug combinations – are they pharmacoeconomically sound? Findings and implications especially for lower- and middle-income countries

    Article • Expert Review of Pharmacoeconomics & Outcomes Research, January 2020, Taylor & Francis

    Amanj Kurdi

  111. A Systematic Review and Meta-Analysis of the Use of Renin-Angiotensin System Blockers and COVID-19 Outcomes: What is the Evidence so Far and the Implications?

    Article • SSRN Electronic Journal, January 2020, Elsevier

    Amanj Kurdi

  112. Ongoing strategies to improve the management of upper respiratory tract infections and reduce inappropriate antibiotic use particularly among lower and middle-income countries: findings and implications for the future

    Article • Current Medical Research and Opinion, December 2019, Taylor & Francis

    Amanj Kurdi, Professor Dr Mainul Haque

  113. Proactive risk assessment of vincristine use process in a teaching and referral hospital in Kenya and the implications

    Article • Journal of Oncology Pharmacy Practice, September 2019, SAGE Publications

    Amanj Kurdi

  114. Pricing of oral generic cancer medicines in 25 European countries; fi ndings and implications

    Article • Generics and Biosimilars Initiative Journal, June 2019, Pro Pharma Communications International

    Amanj Kurdi, Guenka Petrova

  115. Prescribing trends of inhaler treatments for asthma and chronic obstructive pulmonary disease within a resource-constrained environment in the Scottish national health service: findings and implications

    Article • Expert Review of Respiratory Medicine, June 2019, Taylor & Francis

    Amanj Kurdi, Prof Alec Morton

  116. Clinical and economic implications of therapeutic switching of angiotensin receptor blockers to angiotensin-converting enzyme inhibitors

    Article • Journal of Hypertension, June 2019, Wolters Kluwer Health

    Amanj Kurdi

  117. Prevalence of metabolic syndrome among Iranian women with polycystic ovary syndrome: A systematic review and meta-analysis

    Article • Diabetes & Metabolic Syndrome Clinical Research & Reviews, May 2019, Elsevier

    Amanj Kurdi

  118. Adverse effects of chemotherapy and their management in Pediatric patients with Non-Hodgkin’s Lymphoma in Kenya: A descriptive, situation analysis study

    Article • Expert Review of Anticancer Therapy, April 2019, Taylor & Francis

    Amanj Kurdi, Linda Opanga

  119. Ongoing initiatives within the Scottish National Health Service to affect the prescribing of selective serotonin reuptake inhibitors and their influence

    Article • Journal of Comparative Effectiveness Research, April 2019, Future Medicine

    Amanj Kurdi

  120. Feasibility of using point prevalence surveys to assess antimicrobial utilisation in public hospitals in South Africa: a pilot study and implications

    Article • Hospital Practice, March 2019, Taylor & Francis

    Amanj Kurdi, Nokuthula Dlamini

  121. A Systematic Review and Meta-Analysis of Health Literacy in the Iranian Population: Findings and Implications

    Article • Shiraz E-Medical Journal, March 2019, Kowsar Medical Institute

    Amanj Kurdi

  122. Prevalence of depression among Iranian patients with rheumatoid arthritis: a systematic review and meta-analysis

    Article • Open Access Rheumatology Research and Reviews, February 2019, Dove Medical Press

    Reza Ghanei Gheshlagh, Sahar Dalvand, Amanj Kurdi

  123. Health-related quality of life in Iranian patients with type 2 diabetes: An updated meta-analysis

    Article • Diabetes & Metabolic Syndrome Clinical Research & Reviews, January 2019, Elsevier

    Amanj Kurdi

  124. The use of probiotics as a supplementary therapy in the treatment of patients with asthma: a pilot study and implications

    Article • Clinics, January 2019, Fundacao Faculdade de Medicina

    Amanj Kurdi

  125. Antibiotic prescribing patterns at a leading referral hospital in Kenya: A point prevalence survey

    Article • Journal of Research in Pharmacy Practice, January 2019, Medknow

    Amanj Kurdi

  126. Clinical and Financial Implications of Medicine Consumption Patterns at a Leading Referral Hospital in Kenya to Guide Future Planning of Care

    Article • Frontiers in Pharmacology, December 2018, Frontiers

    Amanj Kurdi

  127. Barriers for Access to New Medicines: Searching for the Balance Between Rising Costs and Limited Budgets

    Article • Frontiers in Public Health, December 2018, Frontiers

    Amanj Kurdi, Guenka Petrova

  128. Comparative Effectiveness and Safety of Monoclonal Antibodies (Bevacizumab, Cetuximab, and Panitumumab) in Combination with Chemotherapy for Metastatic Colorectal Cancer: A Systematic Review and Meta-Analysis

    Article • BioDrugs, November 2018, Springer Science + Business Media

    Amanj Kurdi

  129. Antibiotic consumption and antimicrobial resistance in Poland; findings and implications

    Article • Antimicrobial Resistance and Infection Control, November 2018, Springer Science + Business Media

    Amanj Kurdi

  130. Prevalence of poststroke depression in Iranian patients: a systematic review and meta-analysis

    Article • November 2018, Dove Medical Press

    Amanj Kurdi, Reza Ghanei Gheshlagh, Sahar Dalvand

  131. Comparison of Zidovudine and Tenofovir Based Regimens With Regard to Health-Related Quality of Life and Prevalence of Symptoms in HIV Patients in a Kenyan Referral Hospital

    Article • Frontiers in Pharmacology, October 2018, Frontiers

    Amanj Kurdi

  132. Trends in the prescribing of antipsychotic medicines in Pakistan: implications for the future

    Article • Current Medical Research and Opinion, September 2018, Taylor & Francis

    Amanj Kurdi

  133. Adequacy of Dialysis in Iranian Patients Undergoing Hemodialysis: A Systematic Review and Meta-Analysis

    Article • Nephro-Urology Monthly, September 2018, Kowsar Medical Institute

    Amanj Kurdi

  134. Validity of World Health Organisation prescribing indicators in Namibia’s primary healthcare: findings and implications

    Article • International Journal for Quality in Health Care, August 2018, Oxford University Press (OUP)

    Amanj Kurdi

  135. Ongoing activities to optimize the quality and efficiency of lipid-lowering agents in the Scottish national health service: influence and implications

    Article • Expert Review of Pharmacoeconomics & Outcomes Research, August 2018, Taylor & Francis

    Amanj Kurdi, Prof Alec Morton

  136. Abstract

    Article • Pharmacoepidemiology and Drug Safety, August 2018, Wiley

    Amanj Kurdi, Dr Prasad S Nishtala

  137. Prevalence of depression among Iranian patients under hemodialysis: a systematic review and meta-analysis

    Article • Journal of Nephropathology, July 2018, International Society for Phytocosmetic Scicences

    Amanj Kurdi

  138. Evaluation of antihypertensive adherence and its determinants at primary healthcare facilities in rural South Africa

    Article • Journal of Comparative Effectiveness Research, July 2018, Future Medicine

    Amanj Kurdi

  139. Pilot study assessing the direct medical cost of treating patients with cancer in Kenya; findings and implications for the future

    Article • Journal of Medical Economics, June 2018, Taylor & Francis

    Amanj Kurdi

  140. Recent Initiatives in the Republic of Srpska to Enhance Appropriate Use of Antibiotics in Ambulatory Care; Their Influence and Implications

    Article • Frontiers in Pharmacology, May 2018, Frontiers

    Amanj Kurdi

  141. Point prevalence survey of antibiotic use and resistance at a referral hospital in Kenya: findings and implications

    Article • Hospital Practice, April 2018, Taylor & Francis

    Amanj Kurdi

  142. Statin use in Brazil: findings and implications

    Article • Current Medical Research and Opinion, April 2018, Taylor & Francis

    Amanj Kurdi

  143. Drug promotional activities in Nigeria: impact on the prescribing patterns and practices of medical practitioners and the implications

    Article • Hospital Practice, February 2018, Taylor & Francis

    Dr Joseph O Fadare, Dr Olufemi O DESALU, Amanj Kurdi

  144. Ongoing initiatives in Azerbaijan to improve the use of antibiotics; findings and implications

    Article • Expert Review of Anti-infective Therapy, December 2017, Taylor & Francis

    Amanj Kurdi

  145. Assessing Adherence to Antihypertensive Therapy in Primary Health Care in Namibia: Findings and Implications

    Article • Cardiovascular Drugs and Therapy, October 2017, Springer Science + Business Media

    Amanj Kurdi

  146. Prescription patterns and adequacy of blood pressure control among adult hypertensive patients in Kenya; findings and implications

    Article • Expert Review of Clinical Pharmacology, September 2017, Taylor & Francis

    Amanj Kurdi

  147. Exploring factors associated with patients’ adherence to antihypertensive drugs among people with primary hypertension in the United Kingdom

    Article • Journal of Hypertension, September 2017, Wolters Kluwer Health

    Dr Li-Chia Chen, Dr Li-Chia Chen, Amanj Kurdi

  148. Compliance to guidelines for the prescribing of antibiotics in acute infections at Namibia’s national referral hospital: a pilot study and the implications

    Article • Expert Review of Anti-infective Therapy, May 2017, Taylor & Francis

    Amanj Kurdi, Dan Kibuule

  149. Initiatives to increase the prescribing of low cost generics; the case of Scotland in the international context

    Article • Medical Research Archives, January 2017, Knowledge Enterprise Journals

    Amanj Kurdi

  150. The impact of the ‘Better Care Better Value’ prescribing policy on the utilisation of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for treating hypertension in the UK primary care setting: longitudinal quasi-experimental d...

    Article • BMC Health Services Research, June 2015, Springer Science + Business Media

    Dr Li-Chia Chen, Amanj Kurdi